Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Rubinstein

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
BMJ Connections. Oncology|March 23, 2026
Trends in design of FDA registrational randomized clinical trials in hematology and oncology: a 20-year cohort studyCharles J Milrod, Aidan Petrovich, Wayne Liang, et al.
JCO Clinical Cancer Informatics|May 5, 2020
Efficient and Accurate Extracting of Unstructured EHRs on Cancer Therapy Responses for the Development of RECIST Natural Language Processing Tools: Part I, the CorpusYalun Li, Yung-Hung Luo, Jason A Wampfler, et al.
JAMA Network Open|April 13, 2022
Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast CancerXuanyi Li, Alicia Beeghly-Fadiel, Suresh K Bhavnani, et al.
British Journal of Haematology|April 22, 2020
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agentsRobert F Cornell, Samuel Z Goldhaber, Brian G Engelhardt, et al.
JCO Oncology Practice|December 6, 2022
Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social VulnerabilityShakira J Grant, Matthew Jansen, Tzy-Mey Kuo, et al.
Cancers|February 11, 2023
Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational StudyR Dixon Dorand, Neil S Zheng, Rajiv Agarwal, et al.
Blood Cancer Journal|June 11, 2024
Performance of newer myeloma staging systems in a contemporary, large patient cohortGhulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji Kumar, et al.
JCO Precision Oncology|September 14, 2020
Opportunities and Challenges for Analyzing Cancer Data at the Inter- and Intra-Institutional LevelsJulie Wu, Jordan Bryan, Samuel M Rubinstein, et al.
Journal of Geriatric Oncology|December 20, 2024
Association of p16(INK4a), a biomarker of cellular senescence, with receipt of therapy and frailty status among adults with plasma cell disordersChristopher E Jensen, Allison M Deal, Shweta Srikanth, et al.
The Oncologist|May 7, 2017
Impact of Age on Outcomes with Immunotherapy for Patients with MelanomaAllison S Betof, Ryan D Nipp, Anita Giobbie-Hurder, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
BMJ Connections. Oncology|March 23, 2026
Trends in design of FDA registrational randomized clinical trials in hematology and oncology: a 20-year cohort studyCharles J Milrod, Aidan Petrovich, Wayne Liang, et al.
JCO Clinical Cancer Informatics|May 5, 2020
Efficient and Accurate Extracting of Unstructured EHRs on Cancer Therapy Responses for the Development of RECIST Natural Language Processing Tools: Part I, the CorpusYalun Li, Yung-Hung Luo, Jason A Wampfler, et al.
JAMA Network Open|April 13, 2022
Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast CancerXuanyi Li, Alicia Beeghly-Fadiel, Suresh K Bhavnani, et al.
British Journal of Haematology|April 22, 2020
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agentsRobert F Cornell, Samuel Z Goldhaber, Brian G Engelhardt, et al.
JCO Oncology Practice|December 6, 2022
Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social VulnerabilityShakira J Grant, Matthew Jansen, Tzy-Mey Kuo, et al.
Cancers|February 11, 2023
Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational StudyR Dixon Dorand, Neil S Zheng, Rajiv Agarwal, et al.
Blood Cancer Journal|June 11, 2024
Performance of newer myeloma staging systems in a contemporary, large patient cohortGhulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji Kumar, et al.
JCO Precision Oncology|September 14, 2020
Opportunities and Challenges for Analyzing Cancer Data at the Inter- and Intra-Institutional LevelsJulie Wu, Jordan Bryan, Samuel M Rubinstein, et al.
Journal of Geriatric Oncology|December 20, 2024
Association of p16(INK4a), a biomarker of cellular senescence, with receipt of therapy and frailty status among adults with plasma cell disordersChristopher E Jensen, Allison M Deal, Shweta Srikanth, et al.
The Oncologist|May 7, 2017
Impact of Age on Outcomes with Immunotherapy for Patients with MelanomaAllison S Betof, Ryan D Nipp, Anita Giobbie-Hurder, et al.
Pageof 6